article thumbnail

Gamcemetinib

New Drug Approvals

nM) and cell based assays ( EC 50 =89 nM). nM) and cell based assays ( EC 50 =89 nM). Gamcemetinib CAS 1887069-10-4 CC-99677 , OS2IR8TV1O Molecular Weight 469.94 Gamcemetinib CAS 1887069-10-4 CC-99677 , OS2IR8TV1O Molecular Weight 469.94 Gamcemetinib is extracted from patent WO2020236636, compound 1.

article thumbnail

Accelerating Drug Discovery Through Repurposing

DrugBank

Key techniques include high-throughput screening (HTS), cell-based assays, and animal models. Cell-Based Assays In vitro, drug efficacy, and toxicity testing in cell cultures provide valuable preclinical data.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Archbishop Ussher's guide to efficient selection of development candidates

Molecular Design

I would argue that the L2021 study has absolutely no relevance whatsoever to the selection of compounds for development since the team will have data available that enables them to rule out the vast majority of the project compounds for nomination.

article thumbnail

ASLAN Pharmaceuticals to Develop ASLAN003 as Next Generation DHODH Inhibitor in Autoimmune Conditions

The Pharma Data

ASLAN003 is a highly selective and potent inhibitor of human DHODH (IC 50 = 35 nM) and has been shown to be more than 30 times more potent at inhibiting the DHODH enzyme in cell free and cell-based assays than the first generation inhibitor teriflunomide.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

Janne’s passion for the topic of ethics and the future of AI has led her to attend conferences and events to build her knowledge as an attendee and be invited to panels and fireside chats to discuss. From small start-ups through to big pharma, Janne’s experience covers it all.

article thumbnail

Cell Viability Assays – Are your cells happy? | BMG Labtech

BMG Labtech

In measuring cell viability, membrane integrity is a key indicator, as only viable cells with intact membranes are counted as living. Next to cell viability assays, cell-based assays can also be employed to analyse other cellular events like cytotoxicity, reactive oxygen species (ROS) production or cell metabolism.

article thumbnail

Atherosclerotic vascular disease | BMG LABTECH

BMG Labtech

In this blog, we highlight some of the solutions available for researchers to tackle atherosclerotic vascular disease: from fundamental research rooted in ischemia-reperfusion studies and cell-based assays to drug discovery efforts and the early detection of drug-related side effects. What is atherosclerotic vascular disease?

Disease 52